 |
PDBsum entry 2fo0
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
21:787-798
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
|
|
B.Nagar,
O.Hantschel,
M.Seeliger,
J.M.Davies,
W.I.Weis,
G.Superti-Furga,
J.Kuriyan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The tyrosine kinase c-Abl is inactivated by interactions made by its SH3 and SH2
domains with the distal surface of the kinase domain. We present a crystal
structure of a fragment of c-Abl which reveals that a critical N-terminal cap
segment, not visualized in previous structures, buttresses the SH3-SH2
substructure in the autoinhibited state and locks it onto the distal surface of
the kinase domain. Surprisingly, the N-terminal cap is phosphorylated on a
serine residue that interacts with the connector between the SH3 and SH2
domains. Small-angle X-ray scattering (SAXS) analysis shows that a mutated form
of c-Abl, in which the N-terminal cap and two other key contacts in the
autoinhibited state are deleted, exists in an extended array of the SH3, SH2,
and kinase domains. This alternative conformation of Abl is likely to prolong
the active state of the kinase by preventing it from returning to the
autoinhibited state.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Schematic Diagram of the c-Abl Constructs Used and
the Structure of the Cap Region (A) Abl^N-cap was used for
both the crystal structure and SAXS analyses. Residues from the
N-terminal cap in Abl^N-cap that were deleted are indicated with
gray shading, and residues that were included are highlighted in
pink. (B) Surface representation of Abl^N-cap with the cap
region shown as a backbone model in pink. Residues that connect
the cap to the myristoyl but could not be modeled are shown as
pink spheres. Helix αI of the kinase domain is colored purple.
A black box indicates the region magnified in (C). (C)
Hydrophobic surface rendition of Abl^N-cap showing cap
interactions with the SH2 domain and SH3-SH2 connector.
Increasing hydrophobicity of the surface is indicated with
darker shades of green. The cap is shown as sticks, where
carbon, nitrogen, and oxygen atoms are colored orange, blue, and
red, respectively. Labeled are residues that are well ordered
and make direct interactions with the protein. The water
molecule hydrogen bonded to Lys70 is shown as a blue sphere.
Molecular figures were generated with PyMOL (DeLano, 2002).
|
 |
Figure 4.
Figure 4. Shape Reconstructions (A) Kinase domain. The
backbone of the crystal structure of the c-Abl kinase domain
(blue; PDB code 1OPJ) is superimposed onto the shape
reconstruction (shown as green mesh). (B) Abl^N-cap.
Superimposed is the crystal structure of Abl^N-cap shown as a
green backbone onto the shape reconstruction (gray mesh).
(C) Abl^activated. The kinase domain and SH2 and SH3 domains are
colored red, green, and blue, respectively. Indicated on the
right view is the part of the model that may correspond to the
crystal structure of disassembled c-Abl from the original
crystallographic analysis of c-Abl 1b. The SH3 domain was placed
by visual inspection, ensuring that its C terminus was in close
proximity to the N terminus of the SH2 domain.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2006,
21,
787-798)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.R.Groveman,
S.Xue,
V.Marin,
J.Xu,
M.K.Ali,
E.A.Bienkiewicz,
and
X.M.Yu
(2011).
Roles of the SH2 and SH3 domains in the regulation of neuronal Src kinase functions.
|
| |
FEBS J,
278,
643-653.
|
 |
|
|
|
|
 |
J.Yang,
N.Campobasso,
M.P.Biju,
K.Fisher,
X.Q.Pan,
J.Cottom,
S.Galbraith,
T.Ho,
H.Zhang,
X.Hong,
P.Ward,
G.Hofmann,
B.Siegfried,
F.Zappacosta,
Y.Washio,
P.Cao,
J.Qu,
S.Bertrand,
D.Y.Wang,
M.S.Head,
H.Li,
S.Moores,
Z.Lai,
K.Johanson,
G.Burton,
C.Erickson-Miller,
G.Simpson,
P.Tummino,
R.A.Copeland,
and
A.Oliff
(2011).
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
|
| |
Chem Biol,
18,
177-186.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Thai,
P.Y.Ting,
J.McLaughlin,
D.Cheng,
M.Müschen,
O.N.Witte,
and
J.Colicelli
(2011).
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.
|
| |
Leukemia,
25,
290-300.
|
 |
|
|
|
|
 |
N.Jura,
X.Zhang,
N.F.Endres,
M.A.Seeliger,
T.Schindler,
and
J.Kuriyan
(2011).
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.
|
| |
Mol Cell,
42,
9.
|
 |
|
|
|
|
 |
R.E.Iacob,
J.Zhang,
N.S.Gray,
and
J.R.Engen
(2011).
Allosteric interactions between the myristate- and ATP-site of the Abl kinase.
|
| |
PLoS One,
6,
e15929.
|
 |
|
|
|
|
 |
D.W.Sherbenou,
O.Hantschel,
I.Kaupe,
S.Willis,
T.Bumm,
L.P.Turaga,
T.Lange,
K.H.Dao,
R.D.Press,
B.J.Druker,
G.Superti-Furga,
and
M.W.Deininger
(2010).
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.
|
| |
Blood,
116,
3278-3285.
|
 |
|
|
|
|
 |
J.Colicelli
(2010).
ABL tyrosine kinases: evolution of function, regulation, and specificity.
|
| |
Sci Signal,
3,
re6.
|
 |
|
|
|
|
 |
J.Wojcik,
O.Hantschel,
F.Grebien,
I.Kaupe,
K.L.Bennett,
J.Barkinge,
R.B.Jones,
A.Koide,
G.Superti-Furga,
and
S.Koide
(2010).
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.
|
| |
Nat Struct Mol Biol,
17,
519-527.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Rabiller,
M.Getlik,
S.Klüter,
A.Richters,
S.Tückmantel,
J.R.Simard,
and
D.Rauh
(2010).
Proteus in the world of proteins: conformational changes in protein kinases.
|
| |
Arch Pharm (Weinheim),
343,
193-206.
|
 |
|
|
|
|
 |
P.Bernadó
(2010).
Effect of interdomain dynamics on the structure determination of modular proteins by small-angle scattering.
|
| |
Eur Biophys J,
39,
769-780.
|
 |
|
|
|
|
 |
A.Dixit,
and
G.M.Verkhivker
(2009).
Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.
|
| |
PLoS Comput Biol,
5,
e1000487.
|
 |
|
|
|
|
 |
P.Filippakopoulos,
S.Müller,
and
S.Knapp
(2009).
SH2 domains: modulators of nonreceptor tyrosine kinase activity.
|
| |
Curr Opin Struct Biol,
19,
643-649.
|
 |
|
|
|
|
 |
Q.Yin,
S.C.Lin,
B.Lamothe,
M.Lu,
Y.C.Lo,
G.Hura,
L.Zheng,
R.L.Rich,
A.D.Campos,
D.G.Myszka,
M.J.Lenardo,
B.G.Darnay,
and
H.Wu
(2009).
E2 interaction and dimerization in the crystal structure of TRAF6.
|
| |
Nat Struct Mol Biol,
16,
658-666.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.E.Iacob,
T.Pene-Dumitrescu,
J.Zhang,
N.S.Gray,
T.E.Smithgall,
and
J.R.Engen
(2009).
Conformational disturbance in Abl kinase upon mutation and deregulation.
|
| |
Proc Natl Acad Sci U S A,
106,
1386-1391.
|
 |
|
|
|
|
 |
R.E.Joseph,
and
A.H.Andreotti
(2009).
Conformational snapshots of Tec kinases during signaling.
|
| |
Immunol Rev,
228,
74-92.
|
 |
|
|
|
|
 |
X.Liao,
J.Su,
and
M.Mrksich
(2009).
An adaptor domain-mediated autocatalytic interfacial kinase reaction.
|
| |
Chemistry,
15,
12303-12309.
|
 |
|
|
|
|
 |
Y.Choi,
M.A.Seeliger,
S.B.Panjarian,
H.Kim,
X.Deng,
T.Sim,
B.Couch,
A.J.Koleske,
T.E.Smithgall,
and
N.S.Gray
(2009).
N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor.
|
| |
J Biol Chem,
284,
29005-29014.
|
 |
|
|
|
|
 |
A.S.Oh,
J.T.Lahusen,
C.D.Chien,
M.P.Fereshteh,
X.Zhang,
S.Dakshanamurthy,
J.Xu,
B.L.Kagan,
A.Wellstein,
and
A.T.Riegel
(2008).
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
|
| |
Mol Cell Biol,
28,
6580-6593.
|
 |
|
|
|
|
 |
B.Perazzona,
H.Lin,
T.Sun,
Y.Wang,
and
R.Arlinghaus
(2008).
Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.
|
| |
Oncogene,
27,
2208-2214.
|
 |
|
|
|
|
 |
L.M.Rice,
E.A.Montabana,
and
D.A.Agard
(2008).
The lattice as allosteric effector: structural studies of alphabeta- and gamma-tubulin clarify the role of GTP in microtubule assembly.
|
| |
Proc Natl Acad Sci U S A,
105,
5378-5383.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Kosloff,
and
R.Kolodny
(2008).
Sequence-similar, structure-dissimilar protein pairs in the PDB.
|
| |
Proteins,
71,
891-902.
|
 |
|
|
|
|
 |
P.Filippakopoulos,
M.Kofler,
O.Hantschel,
G.D.Gish,
F.Grebien,
E.Salah,
P.Neudecker,
L.E.Kay,
B.E.Turk,
G.Superti-Furga,
T.Pawson,
and
S.Knapp
(2008).
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.
|
| |
Cell,
134,
793-803.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.R.Iyer,
T.J.Pohlhaus,
S.Chen,
G.L.Hura,
L.Dzantiev,
L.S.Beese,
and
P.Modrich
(2008).
The MutSalpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair.
|
| |
J Biol Chem,
283,
13310-13319.
|
 |
|
|
|
|
 |
S.Chen,
L.P.O'Reilly,
T.E.Smithgall,
and
J.R.Engen
(2008).
Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
|
| |
J Mol Biol,
383,
414-423.
|
 |
|
|
|
|
 |
S.Chen,
T.P.Dumitrescu,
T.E.Smithgall,
and
J.R.Engen
(2008).
Abl N-terminal cap stabilization of SH3 domain dynamics.
|
| |
Biochemistry,
47,
5795-5803.
|
 |
|
|
|
|
 |
X.Cao,
K.Q.Tanis,
A.J.Koleske,
and
J.Colicelli
(2008).
Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.
|
| |
J Biol Chem,
283,
31401-31407.
|
 |
|
|
|
|
 |
X.Xiong,
P.Cui,
S.Hossain,
R.Xu,
B.Warner,
X.Guo,
X.An,
A.K.Debnath,
D.Cowburn,
and
L.Kotula
(2008).
Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.
|
| |
Biochim Biophys Acta,
1783,
737-747.
|
 |
|
|
|
|
 |
C.D.Putnam,
M.Hammel,
G.L.Hura,
and
J.A.Tainer
(2007).
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution.
|
| |
Q Rev Biophys,
40,
191-285.
|
 |
|
|
|
|
 |
G.M.Verkhivker
(2007).
In silico profiling of tyrosine kinases binding specificity and drug resistance using Monte Carlo simulations with the ensembles of protein kinase crystal structures.
|
| |
Biopolymers,
85,
333-348.
|
 |
|
|
|
|
 |
G.M.Verkhivker
(2007).
Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
|
| |
Proteins,
66,
912-929.
|
 |
|
|
|
|
 |
J.D.Faraldo-Gómez,
and
B.Roux
(2007).
On the importance of a funneled energy landscape for the assembly and regulation of multidomain Src tyrosine kinases.
|
| |
Proc Natl Acad Sci U S A,
104,
13643-13648.
|
 |
|
|
|
|
 |
J.Sayegh,
K.Webb,
D.Cheng,
M.T.Bedford,
and
S.G.Clarke
(2007).
Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain.
|
| |
J Biol Chem,
282,
36444-36453.
|
 |
|
|
|
|
 |
R.E.Joseph,
D.B.Fulton,
and
A.H.Andreotti
(2007).
Mechanism and functional significance of Itk autophosphorylation.
|
| |
J Mol Biol,
373,
1281-1292.
|
 |
|
|
|
|
 |
S.Chen,
S.Brier,
T.E.Smithgall,
and
J.R.Engen
(2007).
The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
|
| |
Protein Sci,
16,
572-581.
|
 |
|
|
|
|
 |
S.W.Cowan-Jacob,
G.Fendrich,
A.Floersheimer,
P.Furet,
J.Liebetanz,
G.Rummel,
P.Rheinberger,
M.Centeleghe,
D.Fabbro,
and
P.W.Manley
(2007).
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia.
|
| |
Acta Crystallogr D Biol Crystallogr,
63,
80-93.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.A.Leonard,
and
J.H.Hurley
(2007).
Two kinase family dramas.
|
| |
Cell,
129,
1037-1038.
|
 |
|
|
|
|
 |
T.Hunter
(2007).
Treatment for chronic myelogenous leukemia: the long road to imatinib.
|
| |
J Clin Invest,
117,
2036-2043.
|
 |
|
|
|
|
 |
H.K.Lundgren,
and
G.R.Björk
(2006).
Structural alterations of the cysteine desulfurase IscS of Salmonella enterica serovar Typhimurium reveal substrate specificity of IscS in tRNA thiolation.
|
| |
J Bacteriol,
188,
3052-3062.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |